Microinvasive pars plana vitrectomy combined with internal limiting membrane peeling versus anti-VEGF intravitreal injection for treatment-naïve diabetic macular edema (VVV-DME study): study protocol for a randomized controlled trial

BACKGROUND: Diabetic macular edema (DME) is the main cause of vision loss in diabetic patients. Currently, anti-vascular endothelial growth factor (VEGF) intravitreal injection stands as the first-line therapy for DME. However, some patients exhibit insufficient response to anti-VEGF agents and ofte...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Haoxin, Li, Wenbo, Nie, Zetong, Zhang, Xiang, Jiao, Mingfei, Bai, Siqiong, Duan, Naxin, Li, Xiaorong, Hu, Bojie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594908/
https://www.ncbi.nlm.nih.gov/pubmed/37875997
http://dx.doi.org/10.1186/s13063-023-07735-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594908/
https://www.ncbi.nlm.nih.gov/pubmed/37875997
http://dx.doi.org/10.1186/s13063-023-07735-w

Ejemplares similares